{"id":1637,"date":"2024-06-11T13:41:04","date_gmt":"2024-06-11T13:41:04","guid":{"rendered":"https:\/\/novaptech.com\/?page_id=1637"},"modified":"2025-02-28T13:13:18","modified_gmt":"2025-02-28T13:13:18","slug":"biomarker-discovery","status":"publish","type":"page","link":"https:\/\/novaptech.com\/fr\/biomarker-discovery\/","title":{"rendered":"Biomarker discovery | Novaptech"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Le r\u00f4le des aptam\u00e8res dans la visualisation et l'analyse des biomarqueurs<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dans le secteur de la m\u00e9decine de pointe, la recherche et la d\u00e9tection de biomarqueurs sont des \nfacteurs cl\u00e9s pour le diagnostic pr\u00e9coce, le suivi de l'\u00e9volution des maladies et la \npersonnalisation des traitements. \nLes biomarqueurs sont des indicateurs biologiques mesurables que l'on peut trouver dans le \nsang, l'urine, les tissus ou d'autres fluides corporels et qui fournissent des informations cruciales \nsur l'\u00e9tat de sant\u00e9 d'un individu. \nCes mol\u00e9cules, qu'il s'agisse de prot\u00e9ines, d'acides nucl\u00e9iques ou d'autres substances, \npermettent aux m\u00e9decins et aux chercheurs de d\u00e9tecter, de diagnostiquer et de surveiller toute \nune s\u00e9rie de maladies, notamment le cancer, les maladies cardiaques, le diab\u00e8te et bien d'autres. \nLes aptam\u00e8res sont des mol\u00e9cules d'ADN ou d'ARN s\u00e9lectionn\u00e9es en laboratoire pour se lier \nsp\u00e9cifiquement \u00e0 des cibles biologiques. Cette technologie ouvre de nouvelles perspectives \ndans l'analyse des biomarqueurs. Leur capacit\u00e9 \u00e0 cibler pr\u00e9cis\u00e9ment des mol\u00e9cules sp\u00e9cifiques \net leur souplesse de synth\u00e8se en font des outils de choix pour la d\u00e9tection et l'identification des \nbiomarqueurs.<\/p>

Learn more about the revolutionary aptamer technology and its selection process through aptamer SELEX. Understand the benefits of aptamers vs antibodies and explore comprehensive methods of biomarker analysis. Dive into the advanced research conducted in our biotechnology laboratory.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Principaux avantages des aptam\u00e8res par rapport aux anticorps<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Les aptam\u00e8res sont des mol\u00e9cules synth\u00e9tiques pouvant \u00eatre d\u00e9velopp\u00e9es contre tout type de cible, y compris des mol\u00e9cules toxiques ou non immunog\u00e8nes. Leur affinit\u00e9 pour leurs cibles est comparable, voire sup\u00e9rieure, \u00e0 celle des anticorps. Ils sont dix fois plus petits que les anticorps et peuvent \u00eatre modifi\u00e9s chimiquement de mani\u00e8re d\u00e9finie et pr\u00e9cise. Ils se conservent et se transportent facilement, tout en pouvant \u00eatre d\u00e9natur\u00e9s par la chaleur de fa\u00e7on r\u00e9versible puis renatur\u00e9s. Leur approvisionnement est assur\u00e9 avec une reproductibilit\u00e9 totale des synth\u00e8ses d\u2019un lot \u00e0 l\u2019autre.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Ils peuvent \u00eatre utilis\u00e9s dans des conditions non physiologiques \u00e0 des fins analytiques.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

De plus, ils sont non immunog\u00e8nes et peuvent \u00eatre utilis\u00e9s in vivo.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"Aptamers<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tLes services aptam\u00e8res de Novaptech<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Des questions ? Contactez-nous<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vous avez une question sur la s\u00e9lection d\u2019aptam\u00e8res ou le d\u00e9veloppement de tests ?\nVeuillez remplir le formulaire ci-dessous en d\u00e9taillant votre demande afin que nous puissions vous apporter une r\u00e9ponse pr\u00e9cise. Un appel t\u00e9l\u00e9phonique ou une visioconf\u00e9rence peut \u00eatre organis\u00e9(e) si n\u00e9cessaire, et un accord de confidentialit\u00e9 peut \u00eatre sign\u00e9 sur demande. Nous nous engageons \u00e0 vous r\u00e9pondre dans les plus brefs d\u00e9lais (g\u00e9n\u00e9ralement moins de 2 jours ouvr\u00e9s).<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tContactez-nous<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Biomarker\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Votre contact scientifique :<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Jean-Jacques Toulm\u00e9, PhD, CSO<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAnalyse des biomarqueurs via les aptam\u00e8res<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Les aptam\u00e8res sont des mol\u00e9cules d'acide nucl\u00e9ique, soit de l'ADN (acide \nd\u00e9soxyribonucl\u00e9ique), soit de l'ARN (acide ribonucl\u00e9ique), qui sont utilis\u00e9es en m\u00e9decine, en \nrecherche biom\u00e9dicale et en biochimie et chimie analytiques. \nIls se distinguent par leur capacit\u00e9 \u00e0 se lier s\u00e9lectivement et fortement \u00e0 des cibles sp\u00e9cifiques, \nqu'il s'agisse de prot\u00e9ines, de petits compos\u00e9s chimiques ou m\u00eame de cellules.<\/p>

La conception des aptam\u00e8res commence dans le laboratoire de Novaptech, o\u00f9 les chercheurs \nutilisent un processus appel\u00e9 SELEX (Systematic Evolution of Ligands by EXponential \nenrichment) pour isoler les aptam\u00e8res ayant une affinit\u00e9 particuli\u00e8rement \u00e9lev\u00e9e pour la cible \nsouhait\u00e9e. Il s'agit d'un processus complexe en plusieurs \u00e9tapes :<\/p>

1. S\u00e9lection in vitro : le processus de s\u00e9lection commence par une biblioth\u00e8que al\u00e9atoire \nd'oligonucl\u00e9otides (fragments d'ADN ou d'ARN) contenant des milliards de s\u00e9quences \ndiff\u00e9rentes. Ces s\u00e9quences sont expos\u00e9es \u00e0 la cible que l'on souhaite d\u00e9tecter ou cibler. Les \naptam\u00e8res qui se lient \u00e0 la cible sont alors r\u00e9cup\u00e9r\u00e9s.<\/p>

2. Amplification : les s\u00e9quences qui se sont li\u00e9es \u00e0 la cible sont amplifi\u00e9es par PCR (r\u00e9action \nde polym\u00e9risation en cha\u00eene) pour produire une plus grande quantit\u00e9 de candidats.<\/p>

3. R\u00e9p\u00e9tition du processus : ce cycle de s\u00e9lection\/amplification est r\u00e9p\u00e9t\u00e9 plusieurs fois pour \nam\u00e9liorer l'affinit\u00e9 et la sp\u00e9cificit\u00e9 des candidats vis-\u00e0-vis de la cible.<\/p>

4. Validation : les candidats finaux obtenus sont ensuite test\u00e9s pour confirmer leur capacit\u00e9 \u00e0 \nse lier sp\u00e9cifiquement \u00e0 la cible. Les oligonucl\u00e9otides qui r\u00e9pondent aux crit\u00e8res de sp\u00e9cificit\u00e9 \net d'affinit\u00e9 sont des aptam\u00e8res.<\/p>

Ce processus de s\u00e9lection in vitro permet aux chercheurs de Novaptech de g\u00e9n\u00e9rer des \naptam\u00e8res sur mesure pour pratiquement n'importe quelle cible. Une fois obtenus, les aptam\u00e8res \npeuvent \u00eatre utilis\u00e9s de diverses mani\u00e8res, notamment pour la d\u00e9tection de la cible dans divers \n\u00e9chantillons, l'inhibition de l'activit\u00e9 de prot\u00e9ines sp\u00e9cifiques ou m\u00eame l'administration cibl\u00e9e \nde m\u00e9dicaments.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tComment les aptam\u00e8res r\u00e9volutionnent-ils l'analyse des biomarqueurs ?<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Visualisation de biomarqueurs connus \u00e0 l'aide d'aptam\u00e8res<\/strong><\/p>

Production d'aptam\u00e8res marqu\u00e9s : des aptam\u00e8res s\u00e9lectionn\u00e9s sont marqu\u00e9s avec des \nmol\u00e9cules fluorescentes, des enzymes ou des nanoparticules pour faciliter leur d\u00e9tection \nult\u00e9rieure. \nInteraction avec la cible : lorsqu'ils sont expos\u00e9s \u00e0 un \u00e9chantillon biologique contenant la cible \nsouhait\u00e9e, les aptam\u00e8res se lient sp\u00e9cifiquement \u00e0 cette cible. \nD\u00e9tection et quantification : les aptam\u00e8res li\u00e9s \u00e0 la cible sont ensuite d\u00e9tect\u00e9s et quantifi\u00e9s. \nCela peut se faire \u00e0 l'aide de diverses m\u00e9thodes, telles que la colorim\u00e9trie, la fluorescence, \nl'\u00e9lectrochimie ou la PCR, en fonction de la mani\u00e8re dont les aptam\u00e8res ont \u00e9t\u00e9 marqu\u00e9s. \nLes aptam\u00e8res oligonucl\u00e9otidiques, s\u00e9lectionn\u00e9s pour leur grande affinit\u00e9 de liaison avec des \ncibles sp\u00e9cifiques, r\u00e9volutionnent le domaine de la d\u00e9tection biomol\u00e9culaire gr\u00e2ce \u00e0 leur \nflexibilit\u00e9, leur sp\u00e9cificit\u00e9 et leur facilit\u00e9 de modification. \nIls offrent une alternative valid\u00e9e aux anticorps dans une vari\u00e9t\u00e9 d'applications analytiques, \nnotamment dans le d\u00e9veloppement de biocapteurs. \nLa sp\u00e9cificit\u00e9 des aptam\u00e8res d\u00e9coule de leur capacit\u00e9 \u00e0 se replier en structures \ntridimensionnelles permettant une liaison forte et sp\u00e9cifique \u00e0 leur cible, qu'il s'agisse de petites \nmol\u00e9cules, de prot\u00e9ines ou m\u00eame de cellules enti\u00e8res. \nCette sp\u00e9cificit\u00e9 est essentielle pour la d\u00e9tection et les applications analytiques, o\u00f9 la distinction \nentre des mol\u00e9cules similaires permet un diagnostic pr\u00e9cis. \nLa polyvalence des aptam\u00e8res est \u00e9galement un atout majeur. Gr\u00e2ce \u00e0 des modifications \nchimiques, il est possible d'am\u00e9liorer leur stabilit\u00e9 dans des conditions physiologiques, \nd'augmenter leur demi-vie in vivo ou de les doter de groupes fonctionnels facilitant leur \nimmobilisation sur des surfaces de capteurs ou leur marquage avec des sondes fluorescentes ou \n\u00e9lectrochimiques. \nLe d\u00e9veloppement de biocapteurs \u00e0 base d'aptam\u00e8res b\u00e9n\u00e9ficie directement de ces \ncaract\u00e9ristiques. Les aptam\u00e8res peuvent \u00eatre int\u00e9gr\u00e9s dans des syst\u00e8mes de d\u00e9tection qui \ntraduisent la reconnaissance mol\u00e9culaire en un signal \u00e9lectrique ou optique mesurable. \nCette transduction du signal permet une quantification pr\u00e9cise de la cible dans des \u00e9chantillons \ncomplexes, ouvrant la voie \u00e0 des diagnostics rapides, sensibles et peu co\u00fbteux pour un large \n\u00e9ventail d'applications, de la surveillance de l'environnement au diagnostic pr\u00e9coce des \nmaladies. \nL'avenir des aptam\u00e8res dans les biocapteurs est tr\u00e8s prometteur et, gr\u00e2ce \u00e0 son processus de \nrecherche et de d\u00e9veloppement, Novaptech vise \u00e0 am\u00e9liorer encore la sensibilit\u00e9 et la sp\u00e9cificit\u00e9 \ndes syst\u00e8mes de d\u00e9tection. \nL'ing\u00e9nierie des aptam\u00e8res pour des applications cibl\u00e9es pourrait r\u00e9volutionner le diagnostic et \nle traitement des maladies, ainsi que la d\u00e9tection des analytes, affirmant ainsi leur r\u00f4le \nindispensable dans le domaine biom\u00e9dical<\/p>

Avantages des aptam\u00e8res par rapport aux autres outils de d\u00e9tection<\/strong><\/p>

Les aptam\u00e8res offrent plusieurs avantages significatifs par rapport aux autres outils de \nvisualisation et d'analyse des biomarqueurs : \nHaute s\u00e9lectivit\u00e9 : les aptam\u00e8res sont con\u00e7us pour se lier de mani\u00e8re extr\u00eamement sp\u00e9cifique \n\u00e0 leur cible, minimisant ainsi les faux positifs et les interf\u00e9rences. \nFacilit\u00e9 de production : les aptam\u00e8res peuvent \u00eatre produits en grandes quantit\u00e9s, de mani\u00e8re \n\u00e9conomique, relativement simple et reproductible. \nStabilit\u00e9 : contrairement aux prot\u00e9ines, les aptam\u00e8res sont thermiquement stables, ce qui les \nrend id\u00e9aux pour une utilisation dans une vari\u00e9t\u00e9 d'environnements. \nPolyvalence : les aptam\u00e8res peuvent \u00eatre utilis\u00e9s pour d\u00e9tecter une large gamme de \nbiomarqueurs, des prot\u00e9ines aux petites mol\u00e9cules en passant par les cellules.<\/p>

Exemples de visualisation r\u00e9ussie de biomarqueurs \u00e0 l'aide d'aptam\u00e8res<\/strong><\/p>

D\u00e9tection de prot\u00e9ines canc\u00e9reuses : des aptam\u00e8res ont \u00e9t\u00e9 mis au point pour d\u00e9tecter des \nprot\u00e9ines sp\u00e9cifiques associ\u00e9es au cancer, comme le facteur de croissance \u00e9pidermique (EGF) \n50 \ndans le cancer du sein. Ces aptam\u00e8res permettent une d\u00e9tection pr\u00e9coce de la maladie. \nSurveillance des maladies infectieuses : les aptam\u00e8res ont \u00e9t\u00e9 utilis\u00e9s pour d\u00e9tecter des agents \npathog\u00e8nes tels que le VIH, le virus de la dengue et le SARS-CoV-2 (responsable du COVID19), ce qui permet un diagnostic rapide et pr\u00e9cis, notamment gr\u00e2ce \u00e0 l'utilisation de kits et de \ndispositifs de test rapide. \nD\u00e9tection des biomarqueurs cardiaques : des aptam\u00e8res ont \u00e9t\u00e9 mis au point pour d\u00e9tecter \nles biomarqueurs cardiaques tels que la troponine, qui est essentielle pour diagnostiquer les \nprobl\u00e8mes cardiaques. \nLes aptam\u00e8res repr\u00e9sentent une avanc\u00e9e significative dans la d\u00e9tection et l'analyse des \nbiomarqueurs en m\u00e9decine. Leur grande sp\u00e9cificit\u00e9, leur polyvalence et leur facilit\u00e9 de \nproduction en font des outils puissants pour la d\u00e9tection pr\u00e9coce des maladies, les traitements \npersonnalis\u00e9s et la recherche biom\u00e9dicale. \nGr\u00e2ce \u00e0 leur capacit\u00e9 et \u00e0 l'expertise de Novaptech, les aptam\u00e8res repr\u00e9sentent une avanc\u00e9e \nmajeure dans la visualisation et l'analyse des biomarqueurs en m\u00e9decine.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

The role of aptamers in biomarker visualization and analysis In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment. Biomarkers are measurable biological indicators that can be found in blood, urine, tissue or other body fluids, providing crucial information about an individual’s state of health. These molecules, whether proteins, nucleic acids or other substances, enable doctors and researchers to detect, diagnose and monitor a variety of diseases, including cancer, heart disease, diabetes and many others. Aptamers are DNA or RNA molecules selected in the laboratory to bind specifically to biological targets. This technology opens up new perspectives in biomarker analysis. Their ability to precisely target specific molecules and their flexibility oh synthesis make them the tools of choice for the detection and identification of biomarkers. Learn more about the revolutionary aptamer technology and its selection process through aptamer SELEX. Understand the benefits of aptamers vs antibodies and explore comprehensive methods of biomarker analysis. Dive into the advanced research conducted in our biotechnology laboratory. Key advantages of Aptamers over Antibodies Aptamers are synthetic molecules that can be raised against any kind of target, including toxic or non-immunogenic ones. They bind their target with affinity similar or higher than antibodies. They are 10 fold smaller than antibodies and can be chemically-modified at will in a defined and precise way. They can be easily stored and delivered ; they can be reversibly heat-denatured and renatured. The sourcing is guaranteed with a total batch to batch reproducibility. They can be used under non physiological conditions for analytical purposes. They are non\u2013immunogenic and can be used in vivo. Novaptech’s aptamer services Any question ? Contact us Any question about selection service or assay development ? Please fill in the form below with relevant details for helping us providing an informative answer. Telephone or video call can be arranged. NDA can be signed, would you wish so. We will answer you as quickly as possible (generally less than 2 working days). Contact us Your scientific contact : Jean-Jacques Toulm\u00e9, PhD, CSO Analysis of biomarkers via aptamers Aptamers are nucleic acid molecules, either DNA (deoxyribonucleic acid) or RNA (ribonucleic acid), which are used in medicine, biomedical research and analytical biochemistry and chemistry. They are distinguished by their ability to bind selectively and strongly to specific targets, be they proteins, small chemical compounds or even cells. Aptamer design begins in the Novaptech laboratory, where researchers use a process called SELEX (Systematic Evolution of Ligands by EXponential enrichment) to isolate aptamers with a particularly high affinity for the desired target. This is a complex, multi-step process: 1. In vitro selection : The selection process begins with a random library of oligonucleotides (DNA or RNA oligomers) containing billions of different sequences. These sequences are exposed to the target one wishes to detect or target. The aptamers that bind to the target are then recovered. \u00a0 2. Amplification : The sequences that bound to the target are amplified by PCR (polymerase chain reaction) to produce a larger quantity of candidates. 3. Repeating the process : This selection cycle is repeated several times to improve the affinity and specificity of the candidates towards the target. \u00a0 4. Validation : The final candidates obtained are then tested to confirm their ability to bind specifically to the target. Oligonucleotides that meet the specificity and affinity criteria are aptamers. \u00a0 This in vitro selection process enables researchers at Novaptech to generate tailor-made aptamers for virtually any target. Once obtained, aptamers can be used in a variety of ways, including the detection of the target in various samples, inhibition of the activity of specific proteins or even targeted drug delivery. How are aptamers revolutionizing biomarker analysis ? Visualization of known biomarkers using aptamers \u00b7 Production of labeled aptamers : Selected aptamers are labeled with fluorescent molecules, enzymes or nanoparticles to facilitate their subsequent detection. \u00b7 Interaction with the target : When exposed to a biological sample containing the desired target, aptamers bind specifically to that target. \u00b7 Detection and quantification : Aptamers bound to the target are then detected and quantified. This can be done using a variety of methods, such as colorimetry, fluorescence, electrochemistry or PCR, depending on how the aptamers were labeled. 1.\u00b7 Oligonucleotide aptamers selected for their high binding affinity to specific targets, are revolutionizing the field of biomolecular detection, thanks to their flexibility, specificity and ease of modification. 2.\u00b7 They offer a validated alternative to antibodies in a variety of analytical applications, notably in the development of biosensors. 3.\u00b7 The specificity of aptamers derives from their ability to fold into three-dimensional structures enabling strong, specific binding to their target, whether small molecules, proteins or even whole cells. 4.\u00b7 This specificity is essential for detection and analytical applications, where distinguishing between similar molecules provides precise diagnosis. 5.\u00b7 The versatility of aptamers is also a major asset. Thanks to chemical modifications, it is possible to improve their stability under physiological conditions, increase their in vivo half-life or endow them with functional groups facilitating their immobilization on sensor surfaces or labeling with fluorescent or electrochemical probes. 6.\u00b7 The development of aptamer-based biosensors benefits directly from these features. Aptamers can be integrated into detection systems that translate molecular recognition into a measurable electrical or optical signal. 7.\u00b7 This signal transduction enables precise quantification of the target in complex samples, paving the way for rapid, sensitive and inexpensive diagnostics for a wide range of applications, from environmental monitoring to early disease diagnostic. 8.\u00b7 The future of aptamers in biosensors is very promising, and through its research and development process, Novaptech aims to further improve the sensitivity and specificity of detection systems. 9.\u00b7 The engineering of aptamers for targeted applications could revolutionize the diagnosis and treatment of diseases, as well as the detection of analytes further affirming their indispensable role in the biomedical field.10. Advantages of aptamers over other detection tools Aptamers offer several significant advantages over other biomarker visualization and analytical tools \u00b7 High selectivity<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-1637","page","type-page","status-publish","hentry"],"yoast_head":"\nBiomarker discovery | Novaptech - Novaptech<\/title>\n<meta name=\"description\" content=\"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaptech.com\/fr\/biomarker-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarker discovery | Novaptech - Novaptech\" \/>\n<meta property=\"og:description\" content=\"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaptech.com\/fr\/biomarker-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Novaptech\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-28T13:13:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/\",\"url\":\"https:\/\/novaptech.com\/biomarker-discovery\/\",\"name\":\"Biomarker discovery | Novaptech - Novaptech\",\"isPartOf\":{\"@id\":\"https:\/\/novaptech.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\",\"datePublished\":\"2024-06-11T13:41:04+00:00\",\"dateModified\":\"2025-02-28T13:13:18+00:00\",\"description\":\"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaptech.com\/biomarker-discovery\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage\",\"url\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\",\"contentUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaptech.com\/biomarker-discovery\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/novaptech.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomarker discovery | Novaptech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/novaptech.com\/en\/#website\",\"url\":\"https:\/\/novaptech.com\/en\/\",\"name\":\"Novaptech\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/novaptech.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/novaptech.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/novaptech.com\/en\/#organization\",\"name\":\"Novaptech\",\"url\":\"https:\/\/novaptech.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png\",\"contentUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png\",\"width\":335,\"height\":140,\"caption\":\"Novaptech\"},\"image\":{\"@id\":\"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarker discovery | Novaptech - Novaptech","description":"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaptech.com\/fr\/biomarker-discovery\/","og_locale":"fr_FR","og_type":"article","og_title":"Biomarker discovery | Novaptech - Novaptech","og_description":"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.","og_url":"https:\/\/novaptech.com\/fr\/biomarker-discovery\/","og_site_name":"Novaptech","article_modified_time":"2025-02-28T13:13:18+00:00","og_image":[{"url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/novaptech.com\/biomarker-discovery\/","url":"https:\/\/novaptech.com\/biomarker-discovery\/","name":"Biomarker discovery | Novaptech - Novaptech","isPartOf":{"@id":"https:\/\/novaptech.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage"},"image":{"@id":"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","datePublished":"2024-06-11T13:41:04+00:00","dateModified":"2025-02-28T13:13:18+00:00","description":"In the advanced medical sector, biomarker research and detection are key factors in early diagnosis, monitoring disease progression and personalizing treatment.","breadcrumb":{"@id":"https:\/\/novaptech.com\/biomarker-discovery\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaptech.com\/biomarker-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/novaptech.com\/biomarker-discovery\/#primaryimage","url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","contentUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/novaptech.com\/biomarker-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/novaptech.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biomarker discovery | Novaptech"}]},{"@type":"WebSite","@id":"https:\/\/novaptech.com\/en\/#website","url":"https:\/\/novaptech.com\/en\/","name":"Novaptech","description":"","publisher":{"@id":"https:\/\/novaptech.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/novaptech.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/novaptech.com\/en\/#organization","name":"Novaptech","url":"https:\/\/novaptech.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png","contentUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png","width":335,"height":140,"caption":"Novaptech"},"image":{"@id":"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/pages\/1637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/comments?post=1637"}],"version-history":[{"count":29,"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/pages\/1637\/revisions"}],"predecessor-version":[{"id":4379,"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/pages\/1637\/revisions\/4379"}],"wp:attachment":[{"href":"https:\/\/novaptech.com\/fr\/wp-json\/wp\/v2\/media?parent=1637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}